Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $3.4 million.

  • Therapeutics' Accumulated Expenses rose 209.21% to $3.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.4 million, marking a year-over-year increase of 209.21%. This contributed to the annual value of $3.8 million for FY2022, which is N/A changed from last year.
  • Therapeutics' Accumulated Expenses amounted to $3.4 million in Q3 2023, which was up 209.21% from $3.8 million recorded in Q2 2023.
  • Therapeutics' Accumulated Expenses' 5-year high stood at $7.3 million during Q1 2023, with a 5-year trough of $1.2 million in Q1 2022.